These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2162027)

  • 1. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
    Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
    Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
    Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
    Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
    Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
    J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
    Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
    Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
    Losonsky GA; Rennels MB; Kapikian AZ; Midthun K; Ferra PJ; Fortier DN; Hoffman KM; Baig A; Levine MM
    Pediatr Infect Dis; 1986; 5(1):25-9. PubMed ID: 3003715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.
    Vesikari T; Ruuska T; Koivu HP; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1991 Dec; 10(12):912-7. PubMed ID: 1662796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis.
    Pichichero ME
    J Infect Dis; 1990 Sep; 162(3):753-5. PubMed ID: 2167344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field trial of rhesus rotavirus vaccine in infants.
    Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
    Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
    Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
    Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
    Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.
    Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ
    J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
    Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
    J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
    Ho MS; Floyd RL; Glass RI; Pallansch MA; Jones B; Hamby B; Woods P; Penaranda ME; Kapikian AZ; Bohan G
    Pediatr Infect Dis J; 1989 Oct; 8(10):692-6. PubMed ID: 2554244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
    Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
    Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and salivary responses to oral tetravalent reassortant rotavirus vaccine in newborns.
    Friedman MG; Segal B; Zedaka R; Sarov B; Margalith M; Bishop R; Dagan R
    Clin Exp Immunol; 1993 May; 92(2):194-9. PubMed ID: 8387410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
    Vesikari T; Kapikian AZ; Delem A; Zissis G
    J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
    Joensuu J; Koskenniemi E; Vesikari T
    Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.